Pancreas and Coronavirus Disease-2019

Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus affects many other organs than lung and upper airways. Gastrointestinal system appears to be affected both in the upper and in the lower portions. Moreover, hepatic, myocardial, and renal involvements are reported. Furthermore, pancreas can be affected in coronavirus disease-2019 (COVID-19) and the presence of SARS-COV-2 in the pancreatic tissue has been confirmed during autopsy.1

Outstanding Outcome of Pancreatic Cancer: What Lessons Do We Learn

The American Cancer Society’s estimates that 57,600 people (30,400 men and 27,200 women) will be diagnosed with pancreatic cancer in the United States for 2020 and approximately 47,050 people (24,640 men and 22,410 women) will die of pancreatic cancer in 2020.1 Despite advances in first-line therapy such as gemcitabine/nab-paclitaxel and fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in advanced pancreatic cancer (aPC), median overall survival remains less than 12-months.2